Literature DB >> 8005219

Comparison in the immunological properties of Borrelia burgdorferi isolates from Ixodes ricinus derived from three endemic areas in Switzerland.

C M Hu1, S Leuba-Garcia, M D Kramer, A Aeschlimann, L Gern.   

Abstract

Borrelia burgdorferi isolates were obtained from Ixodes ricinus from three sites in Switzerland. They were examined by SDS-PAGE and immunoblotting. The phenotypes, in respect of three outer surface proteins (Osp), differed between the sites of collection. In site 1, most isolates had an OspA of 31 kDa and an OspB of 34 kDa; in site 2, isolates presenting an OspA of 33 kDa dominated and in site 3, the isolates with an OspA of 32 kDa and an OspB of 35 kDa were most frequent. This distribution differed significantly. About half of the isolates from sites 1 and 3 reacted with anti-OspA monoclonal antibody H5332 compared to 29% from site 2. Site 1 isolates reacted significantly more frequently (81%) with another anti-OspA monoclonal antibody LA-31 than isolates from site 3 (P < 0.0001). These findings have implications for the epidemiology of Lyme borreliosis, for the further development of serodiagnostic reagents and for the development of a vaccine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8005219      PMCID: PMC2271501          DOI: 10.1017/s0950268800051232

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  20 in total

1.  Heterogeneity of major proteins in Lyme disease borreliae: a molecular analysis of North American and European isolates.

Authors:  A G Barbour; R A Heiland; T R Howe
Journal:  J Infect Dis       Date:  1985-09       Impact factor: 5.226

2.  Antigenic variability of Borrelia burgdorferi.

Authors:  B Wilske; V Preac-Mursic; G Schierz; R Kühbeck; A G Barbour; M Kramer
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

3.  Lyme disease spirochetes and ixodid tick spirochetes share a common surface antigenic determinant defined by a monoclonal antibody.

Authors:  A G Barbour; S L Tessier; W J Todd
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

Review 4.  Clinical manifestations of Lyme disease.

Authors:  A C Steere; N H Bartenhagen; J E Craft; G J Hutchinson; J H Newman; A R Pachner; D W Rahn; L H Sigal; E Taylor; S E Malawista
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1986-12

5.  Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice.

Authors:  U E Schaible; M D Kramer; K Eichmann; M Modolell; C Museteanu; M M Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

6.  Linear plasmids of the bacterium Borrelia burgdorferi have covalently closed ends.

Authors:  A G Barbour; C F Garon
Journal:  Science       Date:  1987-07-24       Impact factor: 47.728

7.  Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis.

Authors:  A P van Dam; H Kuiper; K Vos; A Widjojokusumo; B M de Jongh; L Spanjaard; A C Ramselaar; M D Kramer; J Dankert
Journal:  Clin Infect Dis       Date:  1993-10       Impact factor: 9.079

8.  Immunochemical and immunological analysis of European Borrelia burgdorferi strains.

Authors:  B Wilske; V Preac-Mursic; G Schierz; K V Busch
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1986-12

9.  Isolation and cultivation of Lyme disease spirochetes.

Authors:  A G Barbour
Journal:  Yale J Biol Med       Date:  1984 Jul-Aug

10.  Discovery of the Lyme disease spirochete and its relation to tick vectors.

Authors:  W Burgdorfer
Journal:  Yale J Biol Med       Date:  1984 Jul-Aug
View more
  7 in total

1.  Tick factors and in vitro cultivation influence the protein profile, antigenicity and pathogenicity of a cloned Borrelia garinii isolate from Ixodes ricinus hemolymph.

Authors:  C M Hu; M Simon; M D Kramer; L Gern
Journal:  Infection       Date:  1996 May-Jun       Impact factor: 3.553

2.  Longterm survey (7 years) in a population at risk for Lyme borreliosis: what happens to the seropositive individuals?

Authors:  H Fahrer; M J Sauvain; E Zhioua; C Van Hoecke; L E Gern
Journal:  Eur J Epidemiol       Date:  1998-02       Impact factor: 8.082

3.  Transmission of Borrelia garinii OspA serotype 4 to BALB/c mice by Ixodes ricinus ticks collected in the field.

Authors:  C M Hu; B Wilske; V Fingerle; Y Lobet; L Gern
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

4.  Distribution of Borrelia burgdorferi sensu lato genomic groups in Europe, a review.

Authors:  Z Hubálek; J Halouzka
Journal:  Eur J Epidemiol       Date:  1997-12       Impact factor: 8.082

5.  Apodemus species mice are reservoir hosts of Borrelia garinii OspA serotype 4 in Switzerland.

Authors:  D Huegli; C M Hu; P-F Humair; B Wilske; L Gern
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

6.  Detection and typing of Borrelia burgdorferi sensu lato in Ixodes ricinus ticks attached to human skin by PCR.

Authors:  G Liebisch; B Sohns; W Bautsch
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

7.  Occurrence of different genospecies of Borrelia burgdorferi sensu lato in ixodid ticks of Valais, Switzerland.

Authors:  O Péter; A G Bretz; D Bee
Journal:  Eur J Epidemiol       Date:  1995-08       Impact factor: 8.082

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.